TON - June 2020, Vol 13, No 3

TON June 2020, Vol 13, No 3 Cover

From The Editor

Mayo Clinic is one of the largest providers of bone marrow transplants in the United States, having performed nearly 10,000 stem-cell transplants at its campuses in Arizona, Florida, and Minnesota. At Mayo Clinic in Rochester, MN, approximately 500 transplants are performed each year. Read More ›

Surgery Is a Viable Treatment Option for Patients with Early-Stage Germ Cell Tumors

This section provides a brief overview of new cancer drugs or new indications approved by the FDA between April 17, 2020, and May 8, 2020. Read More ›

Encorafenib plus Cetuximab Improves Quality of Life  versus Standard of Care in Colorectal Cancer Associated  with BRAF Mutation By Wayne Kuznar

Universal CAR T-Cells a Promising Off-the-Shelf Therapy for T-Cell Acute Lymphoblastic Leukemia

I-SPY 2: Durvalumab plus Olaparib and Paclitaxel Triplet in High-Risk Breast Cancer “Graduates” to Phase 3 Study
“The idea behind the combination was to boost the immune response by adding an anti–PD-1 checkpoint inhibitor, since PARP inhibitors are known to increase the expression of the PD-L1 protein in the tumor,” said Lajos Pusztai, MD, DPhil. Read More ›

Page 1 of 2

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: